- Accelerates Adoption through Complementary Sales Channels
- Enhances 3DS' Metal Printing and Manufacturing Service Capabilities
- Expands 3DS' IP, Technology Platform and Medical Device Productions
- Extends 3DS' Direct Metal Printer Expertise and Product Portfolio
- Expected to be Immediately Accretive to Cash Generation
ROCK HILL, S.C., Sept.
Sign-up for Photo Release -- 3D Systems Acquires LayerWise, Extending Its Global Leadership in Advanced Metal 3D Printing, On-Demand Parts Manufacturing Services and Personalized Medical Devices investment picks
The randomized, double-blind, placebo-controlled, parallel group Phase III study with RHB-102 (the GUARD study) will enroll 320 acute gastroenteritis patients in the U.S. Acute gastroenteritis is an inflammation of the gastrointestinal tract causing nausea and vomiting, with a potential worldwide market estimated to exceed $650 million If approved for marketing by the FDA, RHB-102 is expected to be the first-ever 5-HT3 antagonist drug indicated for acute gastroenteritis Dr.
Sign-up for SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Prosensa Holding N.V. and Its Board of Directors and a Lead Plaintiff Deadline of September 16, 2014 -- RNA investment picks
Sign-up for The Securities Arbitration Law Firm of Klayman & Toskes and Carlo Law Offices File $5 Million Claim Against Popular Securities as a Result of Over-Concentration in Puerto Rico Related Securities investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.